L-Valine (BioCAD00000013164)
blood breast milk cerebrospinal fluid (csf) feces saliva sweat urine epidermis fibroblasts placenta plant natural products microbial natural products
Metabolite Card
Formula: C5H11NO2 (117.079)
SMILES: CC(C)[C@H](N)C(O)=O
Synonyms [en]
L-valine; valine; 2-Amino-3-methylbutyric acid; val; L-valin; L-alpha-Amino-beta-methylbutyric acid
Last reviewed on 2024-06-28.
Cite this Page
L-Valine. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000013164). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
Valine (Val) or L-valine is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Amino acids are organic compounds that contain amino (–NH2) and carboxyl (–COOH) functional groups, along with a side chain (R group) specific to each amino acid. L-valine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Valine is found in all organisms ranging from bacteria to plants to animals. It is classified as a non-polar, uncharged (at physiological pH) aliphatic amino acid. Valine was first isolated from casein in 1901 by Hermann Emil Fischer. The name valine comes from valeric acid, which in turn is named after the plant valerian due to the presence of valine in the roots of the plant. Valine is essential in humans, meaning the body cannot synthesize it, and it must be obtained from the diet. Human dietary sources are foods that contain protein, such as meats, dairy products, soy products, beans and legumes. L-valine is a branched chain amino acid (BCAA). The BCAAs consist of leucine, valine and isoleucine (and occasionally threonine). BCAAs are essential amino acids whose carbon structure is marked by a branch point at the beta-carbon position. BCAAs are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. BCAAs have different metabolic routes, with valine going solely to carbohydrates (glucogenic), leucine solely to fats (ketogenic) and isoleucine being both a glucogenic and a ketogenic amino acid. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine respectively. Like other branched-chain amino acids, the catabolism of valine starts with the removal of the amino group by transamination, giving alpha-ketoisovalerate, an alpha-keto acid, which is converted to isobutyryl-CoA through oxidative decarboxylation by the branched-chain α-ketoacid dehydrogenase complex. This is further oxidised and rearranged to succinyl-CoA, which can enter the citric acid cycle. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist, and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a characteristic urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt. Valine in particular, has been established as a useful supplemental therapy to the ailing liver. Valine, like other branched-chain amino acids, is associated with insulin resistance: higher levels of valine are observed in the blood of diabetic mice, rats, and humans (PMID: 25287287). Mice fed a valine deprivation diet for one day have improved insulin sensitivity and feeding of a valine deprivation diet for one week significantly decreases blood glucose levels (PMID: 24684822). In diet-induced obese and insulin resistant mice, a diet with decreased levels of valine and the other branched-chain amino acids results in reduced adiposity and improved insulin sensitivity (PMID: 29266268). In sickle-cell disease, valine substitutes for the hydrophilic amino acid glutamic acid in hemoglobin. Because valine is hydrophobic, the hemoglobin does not fold correctly. Hypervalinemia is another example of an inborn error of metabolism involving valine.
DBLinks
- CAS Registry Number: 72-18-4
- PubChem CID: 6287
- ChEBI: 16414
- HMDB: HMDB0000883
- LipidMaps:
- KEGG: C00183
- BioCyc: VAL
- NCBI MeSH: Valine
- Wikipedia: L-valine
Other DBLinks
- CAS Registry Number: 25023-78-3
- CAS Registry Number: 25023-80-7
- CAS Registry Number: 516-06-3
- CAS Registry Number: 7004-03-7
- CAS Registry Number: 72-18-4
- CAS Registry Number: 80999-51-5
- CAS Registry Number: 84122-94-1
- PubChem: 1182
- PubChem: 3483
- PubChem: 6287
- ChEBI: ChEBI:16414
- ChEBI: ChEBI:27266
- HMDB: HMDB0000883
- HMDB: HMDB00883
- KEGG: C00183
- KEGG: C00183 D00039
- BioCyc: VAL
- NCBI MeSH: Valine
- Wikipedia: L-valine
- Wikipedia: Valine
- DrugBank: DB00161
- RefMet: RM0136018
- MoNA: CCMSLIB00000577911
- MoNA: CCMSLIB00000578144
- MoNA: EMBL-MCF_spec103039
- MoNA: EMBL-MCF_spec27828
- MoNA: EMBL-MCF_spec27832
- MoNA: EMBL-MCF_spec353465
- MoNA: GLS00011
- MoNA: GLS00012
- MoNA: HMDB0000883_c_ms_912
- MoNA: HMDB0000883_c_ms_967
- MoNA: HMDB0000883_ms_ms_1244
- MoNA: HMDB0000883_ms_ms_1245
- MoNA: HMDB0000883_ms_ms_1246
- MoNA: KNA00025
- MoNA: KNA00026
- MoNA: KNA00027
- MoNA: KNA00028
- MoNA: KNA00232
- MoNA: KNA00233
- MoNA: KNA00234
- MoNA: KNA00235
- MoNA: KO001988
- MoNA: KO001989
- MoNA: KO001990
- MoNA: KO004251
- MoNA: KO004252
- MoNA: KO004253
- MoNA: KO004254
- MoNA: KO004255
- MoNA: KZ000240
- MoNA: KZ000241
- MoNA: MoNA003377
- MoNA: MoNA003378
- MoNA: MoNA003379
- MoNA: MoNA003380
- MoNA: MoNA003381
- MoNA: MoNA003382
- MoNA: MoNA010717
- MoNA: MoNA010718
- MoNA: MoNA010719
- MoNA: MT000075
- MoNA: OUF00333
- MoNA: OUF00334
- MoNA: OUF01002
- MoNA: PB000388
- MoNA: PB000389
- MoNA: PB000390
- MoNA: PB000391
- MoNA: PM000913
- MoNA: PR010070
- MoNA: PR030020
- MoNA: PR100176
- MoNA: PR100588
- MoNA: PS029001
- MoNA: PS029002
- MoNA: PS029003
- MoNA: PS029004
- MoNA: PT102900
- MoNA: PT202900
- MoNA: RP000901
- MoNA: RP000902
- MoNA: RP000903
- MoNA: RP000911
- MoNA: RP000912
- Metlin: METLIN_35
- Coconut NaturalProduct: CNP0152507.1
- Coconut NaturalProduct: CNP0271750.1
- Coconut NaturalProduct: CNP0271750.2
- Coconut NaturalProduct: CNP0271750.3
- Coconut NaturalProduct: CNP0271750.4
- Coconut NaturalProduct: CNP0382124.2
Class / Ontology
- WishartLab ClassyFire: [Amino acids, peptides, and analogues] Amino acids, peptides, and analogues
- RefMet: [Amino acids] Amino acids
- ChEBI: [CHEBI:16414] L-valine
- Coconut NaturalProduct: [Aminoacids] Aminoacids
- Coconut NaturalProduct: [Hydroxy fatty acids] Hydroxy fatty acids
| ID | EC Number | Name |
|---|---|---|
| KEGG:R01212 | 1.4.1.8 | L-valine:NADP+ oxidoreductase (deaminating) |
| KEGG:R01214 | 2.6.1.6 | L-valine:2-oxoglutarate aminotransferase |
| KEGG:R01215 | 2.6.1.66 | L-valine:pyruvate aminotransferase |
| KEGG:R01434 | 1.4.1.9 | L-valine:NAD+ oxidoreductase(deaminating) |
| KEGG:R01437 | 4.1.1.14 | L-valine carboxy-lyase (2-methylpropanamine-forming) |
| KEGG:R02200 | 2.6.1.32 | valine:(S)-3-methyl-2-oxopentanoate aminotransferase |
| KEGG:R03665 | 6.1.1.9 | L-valine:tRNAVal ligase (AMP-forming) |
| KEGG:R04870 | 6.3.2.26 | L-2-aminohexanedioate:L-cysteine:L-valine ligase (AMP-forming, valine-inverting) |
| KEGG:R08663 | 1.14.14.38 | L-valine,[reduced NADPH---hemoprotein reductase]:oxygen oxidoreductase (N-hydroxylating) |
| KEGG:R10031 | 1.14.14.38 | L-valine,[reduced NADPH---hemoprotein reductase]:oxygen oxidoreductase (N-hydroxylating) |
| KEGG:R10941 | 6.3.2.47 | N(beta)-epoxysuccinamoyl-DAP:L-valine ligase (ADP-forming) |
| KEGG:R10942 | 6.3.2.47 | 3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-L-alanine:L-valine ligase (ADP-forming) |
| KEGG:R13429 | 2.1.4.4 | L-arginine:L-valine amidinotransferase |
| BioCyc:VALINE--TRNA-LIGASE-RXN | 6.1.1.9 | VAL-tRNAs + VAL + ATP --> Charged-VAL-tRNAs + PPI + AMP |
| BioCyc:BRANCHED-CHAINAMINOTRANSFERVAL-RXN | 2.6.1.42 | VAL + 2-KETOGLUTARATE<=>GLT + 2-KETO-ISOVALERATE |
| BioCyc:TRANS-RXN-126A | L-valine:Na+ symport | |
| BioCyc:ABC-36-RXN | 7.4.2.2 | ATP + VAL + WATER --> ADP + Pi + VAL + PROTON |
| BioCyc:RXN-23944 | 6.1.1.5 | ILE-tRNAs + VAL + ATP --> Valyl-tRNAIle + PPI + AMP |
| BioCyc:RXN-23945 | 3.1.1.- | Valyl-tRNAIle + WATER --> ILE-tRNAs + VAL + PROTON |
| BioCyc:VALINE-PYRUVATE-AMINOTRANSFER-RXN | 2.6.1.66 | PYRUVATE + VAL<=>L-ALPHA-ALANINE + 2-KETO-ISOVALERATE |
Taxonomy Source
- Allium sativum [ncbi taxid: 4682]
- Aloe africana [ncbi taxid: 1080010]
- Aloe ferox [ncbi taxid: 117798]
- Aloe spicata [ncbi taxid: 992642]
- Aloe vera [ncbi taxid: 34199]
- Angelica acutiloba [ncbi taxid: 55605]
- Angelica gigas [ncbi taxid: 85712]
- Angelica sinensis [ncbi taxid: 165353]
- Aniba canelilla [ncbi taxid: 2803977]
- Anigozanthos flavidus [ncbi taxid: 72643]
- Arabidopsis thaliana [ncbi taxid: 3702]
- Baccharis hutchisonii [ncbi taxid: ]
- Brassica juncea [ncbi taxid: 3707]
- Brassica oleracea var. sabauda [ncbi taxid: 1216010]
- Calvatia fenzlii [ncbi taxid: 626502]
- Calvatia gigantea [ncbi taxid: 68762]
- Calvatia lilacina [ncbi taxid: 2979578]
- Chlamydomonas reinhardtii [ncbi taxid: 3055]
- Comptonia peregrina [ncbi taxid: 29742]
- Curcuma domestica [ncbi taxid: ]
- Escherichia coli [ncbi taxid: 562]
- FOOD SAKE [ncbi taxid: ]
- Ginkgo biloba [ncbi taxid: 3311]
- Herba sedi sarmentosi [ncbi taxid: ]
- Homo sapiens [ncbi taxid: 9606]
- Isatis tinctoria [ncbi taxid: 161756]
- Leptodontidium elatius [ncbi taxid: 187858]
- Macowania corymbosa [ncbi taxid: ]
- Methylomonas methanica [ncbi taxid: 421]
- Mus musculus [ncbi taxid: 10090]
- Origanum floribundum [ncbi taxid: ]
- Passalora rosicola [ncbi taxid: ]
- Pisum sativum [ncbi taxid: ]
- Pogostemon cablin [ncbi taxid: 28511]
- Saccharomyces cerevisiae [ncbi taxid: 4932]
- Salvia hispanica [ncbi taxid: 49212]
- Sinapis alba [ncbi taxid: 3728]
- Solanum lycopersicum [ncbi taxid: 4081]
- Spinacia oleracea [ncbi taxid: 3562]
- Streptomyces jiujiangensis JXJ 0074 [ncbi taxid: ]
- Streptomyces sp. DST25 [ncbi taxid: 1574178]
- Taraxacum borealisinense [ncbi taxid: ]
- Taraxacum coreanum [ncbi taxid: 1041103]
- Taraxacum mongolicum [ncbi taxid: 90037]
- Taraxacum officinale [ncbi taxid: 50225]
- Taraxacum platycarpum [ncbi taxid: 170727]
- Tussilago farfara [ncbi taxid: 118778]
- Streptomyces flavidovirens SANK 60486 [ncbi taxid: ]
Pathway Synthetic
| pathway id | name |
|---|---|
| BioCyc:LEISH_VALDEG-PWY | valine degradation I |
| BioCyc:LEISH_TRNA-CHARGING-PWY | tRNA charging pathway |
| BioCyc:TRYPANO_VALDEG-PWY | valine degradation I |
| BioCyc:TRYPANO_PWY0-1061 | superpathway of alanine biosynthesis |
| BioCyc:TRYPANO_ALANINE-VALINESYN-PWY | alanine biosynthesis I |
| PathBank:SMP0000810 | L-Alanine Metabolism |
| PathBank:SMP0000820 | tRNA Charging |
| PathBank:SMP0000824 | tRNA Charging 2 |
| PathBank:SMP0000832 | Valine Biosynthesis |
| PathBank:SMP0000994 | Secondary Metabolites: Valine and L-Leucine Biosynthesis from Pyruvate |
| WikiPathways:WP3604 | Biochemical pathways: part I |
| WikiPathways:WP3953 | mRNA, protein, and metabolite inducation pathway by cyclosporin A |
| WikiPathways:WP2 | Valine biosynthesis |
| WikiPathways:WP3622 | AtMetExpress overview |
| WikiPathways:WP4599 | Glucosinolate biosynthesis from branched-chain amino acid |
| WikiPathways:WP662 | Amino acid metabolism |
| WikiPathways:WP661 | Glucose homeostasis |
| WikiPathways:WP1451 | Valine, leucine and isoleucine degradation |
| WikiPathways:WP3925 | Amino acid metabolism |
| WikiPathways:WP4233 | Acrylamide biotransformation and exposure biomarkers |